Alembic Pharmaceuticals Limited passes ANVISA, Brazil GMP audit for its API-II Facility at Panelav

Alembic Pharmaceuticals Limited has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facility at Panelav for its 8 APIs. The inspection was conducted from 16th September, 2024 to 20th September, 2024.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 1103.75 as compared to the previous close of Rs. 1103.20. The total number of shares traded during the day was 6399 in over 533 trades.

The stock hit an intraday high of Rs. 1117.40 and intraday low of 1094.90. The net turnover during the day was Rs. 7076555.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 ANVISA GMPAudit API2Facility Panelav 8APIs